Skip to content

10-KAccepted Mar 17, 4:03 PM ET

AN2 Therapeutics, Inc. 10-K

ANTXAN2 Therapeutics, Inc.

Accepted (ET)

4:03 PM

Mar 17, 2026

Filed

Mar 17, 2026

Documents

77

Size

10.4 MB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.